Overexpression of glypican-1 implicates poor prognosis and their chemoresistance in oesophageal squamous cell carcinoma

BACKGROUND: Despite the recent improvements in multimodal therapies for oesophageal squamous cell carcinoma (ESCC), the prognosis remains poor. The identification of suitable biomarkers for predicting the prognosis and chemo-sensitivity is required to develop targeted treatments and improve treatmen...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Br J Cancer
Main Authors: Hara, Hisashi, Takahashi, Tsuyoshi, Serada, Satoshi, Fujimoto, Minoru, Ohkawara, Tomoharu, Nakatsuka, Rie, Harada, Emi, Nishigaki, Takahiko, Takahashi, Yusuke, Nojima, Satoshi, Miyazaki, Yasuhiro, Makino, Tomoki, Kurokawa, Yukinori, Yamasaki, Makoto, Miyata, Hiroshi, Nakajima, Kiyokazu, Takiguchi, Shuji, Morii, Eiichi, Mori, Masaki, Doki, Yuichiro, Naka, Tetsuji
פורמט: Artigo
שפה:Inglês
יצא לאור: Nature Publishing Group 2016
נושאים:
Molecular Diagnostics
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC4931380/
https://ncbi.nlm.nih.gov/pubmed/27310703
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2016.183
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים